STOCK TITAN

Bay Hematology Oncology and American Oncology Network Welcome Dr. Bill Gai

(Very Positive)
Tags

American Oncology Network (NASDAQ:AONC) partner practice Bay Hematology Oncology in Maryland has added Board-certified medical oncologist and hematologist Bill Gai, MD, PhD, MS to its physician team.

According to American Oncology Network, Dr. Gai will see patients in Easton and Centreville and brings extensive academic, research and clinical experience.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

This announcement adds an experienced hematologist-oncologist and highlights BHO’s four advanced pra...
Analysis

This announcement adds an experienced hematologist-oncologist and highlights BHO’s four advanced practitioners, modestly strengthening AONC’s community-oncology footprint. Prior physician and practice additions have produced mixed price reactions, so investors may watch how integration and patient growth progress from here.

Key Figures

Fellowship completion: June 2010 Kahlert role start: June 2017 Medical director tenure: Jan 2023–Oct 2025 +1 more
4 metrics
Fellowship completion June 2010 Completed hematology-oncology fellowship at University of Maryland Greenebaum Cancer Center
Kahlert role start June 2017 Began attending hematologist and oncologist role at Kahlert Regional Cancer Center
Medical director tenure Jan 2023–Oct 2025 Served as medical director for Kahlert Regional Cancer Center
Advanced practitioners 4 Number of advanced practitioners on Bay Hematology Oncology care team

Historical Context

5 past events · Latest: Jun 09 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 09 Physician addition Positive -99.2% Florida partner practice added a new board-certified medical oncologist and hematologist.
May 21 Academic affiliation Positive +0.0% Partner center became an affiliate of OSUCCC – James, expanding access to 500+ trials.
Apr 30 Physician addition Positive +2.8% MidAmerica Cancer Care welcomed a new board-certified medical oncologist to its team.
Apr 22 Conference participation Positive +16.1% AON leaders scheduled to deliver 11 sessions at a major community oncology conference.
Mar 05 Practice acquisition Positive -7.3% Oncology Consultants joined AON, expanding locations and specialist coverage in South Texas.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

AONC often reacts positively to network and visibility news, but some practice-expansion headlines have coincided with sharp downside moves.

Key Terms

hematology-oncology fellowship
1 terms
hematology-oncology fellowship medical
"and a hematology-oncology fellowship at the University of Maryland Greenebaum"
A hematology-oncology fellowship is an advanced medical training program where doctors specialize in diagnosing and treating blood disorders and cancers, similar to an apprenticeship that builds deep clinical and research skills beyond general medical training. For investors, the presence of fellowship-trained staff or programs signals higher scientific expertise and stronger capability to run clinical trials, interpret results, and engage regulators—factors that can affect a healthcare company's credibility and the perceived likelihood of successful drug development.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

EASTON, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Community oncology practice Bay Hematology Oncology (BHO), a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified medical oncologist and hematologist Bill Gai, MD, PhD, MS, to its physician care team. Dr. Gai is now accepting patients at the practice’s Easton and Centreville locations.

13931_BHO_Bill-Gai_Press-Release_Headshot_260625_FINAL

Dr. Gai earned his medical degree from Shandong Medical University and a Master of Science in molecular cell biology from Capital Medical University in Beijing before moving to the United States to pursue advanced scientific training. He earned a Ph.D. in molecular and cell biology from Ohio University and completed postdoctoral research at Washington University in St. Louis. He then completed an internal medicine residency at St. Luke’s Hospital in St. Louis and a hematology-oncology fellowship at the University of Maryland Greenebaum Comprehensive Cancer Center in Baltimore, completing his fellowship in June 2010. Dr. Gai’s first attending physician role was at Bay Hematology Oncology, where he developed his clinical foundation and built lasting professional relationships. Prior to rejoining Bay Hematology Oncology, Dr. Gai worked as an attending hematologist and oncologist at Kahlert Regional Cancer Center associated with Lifebridge Health System starting in June 2017. He also served as medical director for the cancer center from January 2023 to October 2025.

“I am excited to join Bay Hematology Oncology,” said Dr. Gai. “BHO’s commitment to high-quality, physician led, patient-centered care aligns with my approach to medicine. I look forward to collaborating with the team to continue providing exceptional cancer care to patients in our community.”

Bay Hematology Oncology includes a team of accomplished physicians, including Muhammad Siddique, MD, and Pamela Simpson, MD, as well as a dedicated care staff of four advanced practitioners experienced in treating a wide range of blood disorders and cancer-related diseases. The practice has locations in Easton and Centreville.

“We are thrilled to welcome Dr. Gai back to Bay Hematology Oncology,” said Muhammad Siddique, MD, medical oncologist and hematologist at BHO. “His impressive academic background and clinical expertise make him an excellent addition to our team. Our patients and community will benefit from his commitment to delivering compassionate, personalized care.”

“On behalf of AON, I am pleased to welcome Dr. Gai to Bay Hematology Oncology and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “I am confident that his addition will strengthen the high-quality community oncology care we provide in Maryland and across our network.”

For more information about AON, visit AONcology.com. For more information about Bay Hematology Oncology, visit bayhematologyoncology.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedInFacebookX (formerly Twitter) and YouTube.

About Bay Hematology Oncology
Bay Hematology Oncology treats a full range of blood disorders and cancer-related diseases, from cancers of the blood, skin, and lymph system to cancers of the solid organs. The staff and experienced physicians take a multidisciplinary approach, combining medical, radiation and surgical oncology to help patients on the road to recovery. The practice is committed to bringing the latest technologies and advanced treatment options to patients. Together, they help patients with therapies to reduce side effects, boost their energy levels, and keep them strong during treatment. Learn more at www.bayhematologyoncology.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/363eaa53-dbdb-4408-8f9b-e5680c9eb519



Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

FAQ

Who is Dr. Bill Gai joining Bay Hematology Oncology and AONC in July 2026?

Dr. Bill Gai is a Board-certified medical oncologist and hematologist joining Bay Hematology Oncology’s care team. According to American Oncology Network, he holds an MD, PhD and MS, with advanced training in molecular and cell biology and extensive clinical experience in hematology-oncology.

When and where will Dr. Bill Gai see patients under AONC at Bay Hematology Oncology?

Dr. Bill Gai is now accepting patients at Bay Hematology Oncology’s Easton and Centreville locations. According to American Oncology Network, he joins the community oncology practice to support cancer and blood-disorder care for patients across Maryland’s Eastern Shore region.

What is Dr. Bill Gai’s medical and scientific background relevant to AONC patients?

Dr. Bill Gai trained in molecular and cell biology and hematology-oncology before joining Bay Hematology Oncology. According to American Oncology Network, he earned a PhD at Ohio University, completed postdoctoral research at Washington University, and finished a hematology-oncology fellowship in Baltimore in 2010.

What roles did Dr. Bill Gai hold before rejoining Bay Hematology Oncology and AONC?

Before rejoining Bay Hematology Oncology, Dr. Bill Gai served at Kahlert Regional Cancer Center. According to American Oncology Network, he worked as an attending hematologist-oncologist from June 2017 and was medical director from January 2023 through October 2025.

How does Dr. Bill Gai’s arrival support American Oncology Network (AONC) care in Maryland?

Dr. Bill Gai’s addition is intended to strengthen community oncology care in Maryland. According to American Oncology Network, his academic background, clinical expertise and commitment to compassionate, personalized care are expected to benefit patients served by Bay Hematology Oncology and the broader AON network.